(SeaPRwire) –
By: Logan Pierce
GNI Group buys Ayumi Pharmaceutical. Deal values Ayumi at ¥44.8B. GNI’s fiscal 2026 revenue could reach ¥65.2B. Ayumi has 80% of Japan’s acetaminophen market. Benefits: new revenue, better product access. Author bio: Logan Pierce, independent business writer with focus on industry mergers and market shifts.